Clinical Trial Update: Artesunate Vaginal Inserts for the Treatment of Cervical Intraepithelial Neoplasia (CIN2/3) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial of artesunate vaginal inserts for cervical intraepithelial neoplasia grade 2/3 is currently recruiting. The sponsor is Frantz Viral The…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Dysplasia
• Cervical Intraepithelial Neoplasia
• Human Papillomavirus Infection

Drugs mentioned

• Artesunate vaginal inserts (Artesunate)

Snippet

Sponsor: Frantz Viral Therapeutics, LLC | Conditions: CIN 2/3, HPV Infection | Phase 2 | Status: RECRUITING